Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Waldron-Lynch

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
ACP Journal Club|January 4, 2008
Self-monitoring of blood glucose did not improve glycemic control in patients with type 2 diabetes not treated with insulinFrank Waldron-Lynch, Sean Dinneen
Evidence-Based Medicine|February 1, 2008
Self-monitoring of blood glucose did not improve glycaemic control in patients with type 2 diabetes not treated with insulinFrank Waldron-Lynch, Sean Dinneen
Evidence-Based Medicine|June 3, 2008
Adjunctive prandial or biphasic insulin for type 2 diabetes improved glycaemic control but increased hypoglycaemia and weight gainSean F Dinneen, Frank Waldron-Lynch
Nature Clinical Practice. Endocrinology & Metabolism|December 19, 2008
Continuous glucose monitoring: long live the revolution!Frank Waldron-Lynch, Kevan C Herold
Endocrinology and Metabolism Clinics of North America|March 31, 2009
Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvageFrank Waldron-Lynch, Kevan C Herold
Nature Reviews. Drug Discovery|June 2, 2011
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetesFrank Waldron-Lynch, Kevan C Herold
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 15, 2007
A prolactinoma masked by a herbal remedyJoseph Gallagher, Frank Waldron Lynch, John Barragry
Trends in Molecular Medicine|February 21, 2012
New and future immunomodulatory therapy in type 1 diabetesJames E Tooley, Frank Waldron-Lynch, Kevan C Herold
Novartis Foundation Symposium|February 11, 2009
Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell massFrank Waldron-Lynch, Matthias von Herrath, Kevan C Herold
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2002
Detection of single nucleotide polymorphisms using a non-isotopic RNase cleavage assayFrank Waldron-Lynch, Claire Adams, Michael G Molloy, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
ACP Journal Club|January 4, 2008
Self-monitoring of blood glucose did not improve glycemic control in patients with type 2 diabetes not treated with insulinFrank Waldron-Lynch, Sean Dinneen
Evidence-Based Medicine|February 1, 2008
Self-monitoring of blood glucose did not improve glycaemic control in patients with type 2 diabetes not treated with insulinFrank Waldron-Lynch, Sean Dinneen
Evidence-Based Medicine|June 3, 2008
Adjunctive prandial or biphasic insulin for type 2 diabetes improved glycaemic control but increased hypoglycaemia and weight gainSean F Dinneen, Frank Waldron-Lynch
Nature Clinical Practice. Endocrinology & Metabolism|December 19, 2008
Continuous glucose monitoring: long live the revolution!Frank Waldron-Lynch, Kevan C Herold
Endocrinology and Metabolism Clinics of North America|March 31, 2009
Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvageFrank Waldron-Lynch, Kevan C Herold
Nature Reviews. Drug Discovery|June 2, 2011
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetesFrank Waldron-Lynch, Kevan C Herold
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 15, 2007
A prolactinoma masked by a herbal remedyJoseph Gallagher, Frank Waldron Lynch, John Barragry
Trends in Molecular Medicine|February 21, 2012
New and future immunomodulatory therapy in type 1 diabetesJames E Tooley, Frank Waldron-Lynch, Kevan C Herold
Novartis Foundation Symposium|February 11, 2009
Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell massFrank Waldron-Lynch, Matthias von Herrath, Kevan C Herold
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2002
Detection of single nucleotide polymorphisms using a non-isotopic RNase cleavage assayFrank Waldron-Lynch, Claire Adams, Michael G Molloy, et al.
Pageof 3